Quarterly report · Q1
3353.TEDINET S100REIO
Period2023-03-01 → 2023-05-31
Filed2023-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.7bn | 2023-03-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥33.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2022-03-01 → 2022-05-31 | Cons. | Net sales |
| Operating income | ¥294m | 2023-03-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥239m | 2022-03-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥338m | 2023-03-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥313m | 2022-03-01 → 2022-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥375m | 2023-03-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥334m | 2022-03-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥212m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥760m | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥208m | 2022-03-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥224m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥213m | 2022-03-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥28.1bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥28.8bn | at 2022-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.4bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥14.9bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥12.7bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥12.0bn | at 2022-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| EPS (basic) | ¥56.42 | 2023-03-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥202.2 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.39 | 2022-03-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 43.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.8% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-05-31 | −¥187m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥375m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥1.1bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥810m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥275m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥23m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥47m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-05-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-05-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥277m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-05-31 | ¥481m |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-05-31 | −¥253m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-05-31 | −¥253m |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-05-31 | −¥189m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥363m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥19m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥946m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥694m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥252m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥16m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥49m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥49m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥381,000 |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥30m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-03-01 → 2022-05-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-03-01 → 2022-05-31 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥253m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-03-01 → 2022-05-31 | ¥428m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 355
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 312900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 312900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0768 | |
| Cash and deposits | Prior1YearInstant | 6443169000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 6651290000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 5009077000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 5184958000 | JPY |
| Merchandise | Prior1YearInstant | 1228229000 | JPY |
| Merchandise | CurrentQuarterInstant | 1253116000 | JPY |
| Other ca | Prior1YearInstant | 561431000 | JPY |
| Other ca | CurrentQuarterInstant | 660164000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -2388000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -2388000 | JPY |
| Current assets | Prior1YearInstant | 13239518000 | JPY |
| Current assets | CurrentQuarterInstant | 13747141000 | JPY |
| Buildings and structures net | Prior1YearInstant | 5506241000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 5412056000 | JPY |
| Land | Prior1YearInstant | 3762342000 | JPY |
| Land | CurrentQuarterInstant | 3762342000 | JPY |
| Other net ppe | Prior1YearInstant | 318822000 | JPY |
| Other net ppe | CurrentQuarterInstant | 386793000 | JPY |
| Property plant and equipment | Prior1YearInstant | 9587406000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 9561192000 | JPY |
| Goodwill | Prior1YearInstant | 1296414000 | JPY |
| Goodwill | CurrentQuarterInstant | 1246194000 | JPY |
| Other ia | Prior1YearInstant | 182529000 | JPY |
| Other ia | CurrentQuarterInstant | 180172000 | JPY |
| Intangible assets | Prior1YearInstant | 1478943000 | JPY |
| Intangible assets | CurrentQuarterInstant | 1426366000 | JPY |
| Investment securities | Prior1YearInstant | 1320428000 | JPY |
| Investment securities | CurrentQuarterInstant | 1261798000 | JPY |
| Lease and guarantee deposits | Prior1YearInstant | 1047449000 | JPY |
| Lease and guarantee deposits | CurrentQuarterInstant | 1045230000 | JPY |
| Other ioa | Prior1YearInstant | 832031000 | JPY |
| Other ioa | CurrentQuarterInstant | 1039466000 | JPY |
| Investments and other assets | Prior1YearInstant | 3199908000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 3346495000 | JPY |
| Noncurrent assets | Prior1YearInstant | 14266258000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 14334053000 | JPY |
| Assets | Prior1YearInstant | 27505776000 | JPY |
| Assets | CurrentQuarterInstant | 28081195000 | JPY |
| Notes payable trade | Prior1YearInstant | 45553000 | JPY |
| Notes payable trade | CurrentQuarterInstant | 50889000 | JPY |
| Accounts payable trade | Prior1YearInstant | 3393285000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 3635693000 | JPY |
| Short term loans payable | Prior1YearInstant | 170000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 200000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 2694980000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 2611341000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |